Correlation Between PHARMACOLOG and Dow Jones
Can any of the company-specific risk be diversified away by investing in both PHARMACOLOG and Dow Jones at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PHARMACOLOG and Dow Jones into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PHARMACOLOG I UPPSALA and Dow Jones Industrial, you can compare the effects of market volatilities on PHARMACOLOG and Dow Jones and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PHARMACOLOG with a short position of Dow Jones. Check out your portfolio center. Please also check ongoing floating volatility patterns of PHARMACOLOG and Dow Jones.
Diversification Opportunities for PHARMACOLOG and Dow Jones
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between PHARMACOLOG and Dow is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding PHARMACOLOG I UPPSALA and Dow Jones Industrial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dow Jones Industrial and PHARMACOLOG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PHARMACOLOG I UPPSALA are associated (or correlated) with Dow Jones. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dow Jones Industrial has no effect on the direction of PHARMACOLOG i.e., PHARMACOLOG and Dow Jones go up and down completely randomly.
Pair Corralation between PHARMACOLOG and Dow Jones
If you would invest 0.00 in PHARMACOLOG I UPPSALA on October 10, 2024 and sell it today you would earn a total of 0.00 from holding PHARMACOLOG I UPPSALA or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 4.55% |
| Values | Daily Returns |
PHARMACOLOG I UPPSALA vs. Dow Jones Industrial
Performance |
| Timeline |
PHARMACOLOG and Dow Jones Volatility Contrast
Predicted Return Density |
| Returns |
PHARMACOLOG I UPPSALA
Pair trading matchups for PHARMACOLOG
Dow Jones Industrial
Pair trading matchups for Dow Jones
Pair Trading with PHARMACOLOG and Dow Jones
The main advantage of trading using opposite PHARMACOLOG and Dow Jones positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PHARMACOLOG position performs unexpectedly, Dow Jones can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dow Jones will offset losses from the drop in Dow Jones' long position.| PHARMACOLOG vs. ORMAT TECHNOLOGIES | PHARMACOLOG vs. Sterling Construction | PHARMACOLOG vs. PKSHA TECHNOLOGY INC | PHARMACOLOG vs. Sunny Optical Technology |
| Dow Jones vs. Thai Beverage PCL | Dow Jones vs. ServiceNow | Dow Jones vs. Loud Beverage Group | Dow Jones vs. Suntory Beverage Food |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |